Paper Details

  1. Home
  2. Paper Details

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.

Author: Al-HendyAyman, Arjona FerreiraJuan C, CritchleyHilary O D, LangenbergAndria G M, LiYulan, LukesAndrea S, McKainLaura, PoindexterAlfred N, StewartElizabeth A, VenturellaRoberta, VillarroelClaudio, WagmanRachel B

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Uterine fibroids, which can cause heavy bleeding and pain, may be treated with a daily combination of relugolix, estradiol, and norethindrone acetate. This combination aims to reduce symptoms while avoiding the side effects of low estrogen levels.
Paper Details　
Original Abstract of the Article :
Uterine fibroids are a common cause of heavy menstrual bleeding and pain. Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone-receptor antagonist), estradiol, and norethindrone acetate, administered once daily, may have efficacy in women with uterine fibroids and heav...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/33596357

データ提供：米国国立医学図書館（NLM）

A New Oasis in the Desert of Uterine Fibroids

This research explores the potential of relugolix combination therapy for managing uterine fibroids, a common cause of heavy menstrual bleeding and pain. The researchers investigated the efficacy of a once-daily combination therapy consisting of relugolix, estradiol, and norethindrone acetate in women with uterine fibroids. This research, much like seeking a wellspring of knowledge in a vast desert, aims to find new and effective treatment options for a common medical condition.

A Promising Approach to Uterine Fibroids

The research suggests that relugolix combination therapy might be a promising option for women with uterine fibroids and heavy bleeding, offering potential relief from symptoms while avoiding the hypoestrogenic effects associated with other treatments. This discovery, like finding a fertile oasis in a dry desert, offers a potential solution for women seeking relief from the debilitating symptoms of uterine fibroids.

A New Horizon for Women's Health

This research, like a guiding star in the night sky, points towards a new horizon in the management of uterine fibroids. The potential of relugolix combination therapy offers hope for women seeking effective and safe treatment options. Further research will undoubtedly illuminate the full potential of this promising new approach to women's health.

Dr.Camel's Conclusion

This research, like a refreshing oasis in the desert of uterine fibroids, explores the potential of a new treatment combination, offering hope for women seeking relief from debilitating symptoms.

Date :
  1. Date Completed 2021-02-23
  2. Date Revised 2022-02-11
Further Info :

Pubmed ID

33596357

DOI: Digital Object Identifier

NIHMS1714474

Related Literature

Article Analysis
・Effective treatment of uterine fibroids
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.